Adrenergic targets for the treatment of cognitive deficits in schizophrenia

[1] Aoki undefined(1994)undefined Brain Res 650 181-undefined

[2] Aoki undefined(1998)undefined Cereb Cortex 8 269-undefined

[3] Arnsten undefined(1997)undefined J Psychopharmacol 11 151-undefined

[4] Arnsten undefined(1998)undefined Trends Cognit Sci 2 436-undefined

[5] Arnsten undefined(1993)undefined Neurobiol Aging 14 597-undefined

[6] Arnsten undefined(1992)undefined Psychopharmacology 108 159-undefined

[7] Arnsten undefined(1985)undefined Science 230 1273-undefined

[8] Arnsten undefined(1986)undefined Soc Neurosci Abstr 12 1464-undefined

[9] Arnsten undefined(1998)undefined Arch Gen Psychiatry 55 362-undefined

[10] Arnsten undefined(1988)undefined J Neurosci 8 4287-undefined

[1] Aoki undefined(1994)undefined Brain Res 650 181-undefined

[2] Aoki undefined(1998)undefined Cereb Cortex 8 269-undefined

[3] Arnsten undefined(1997)undefined J Psychopharmacol 11 151-undefined

[4] Arnsten undefined(1998)undefined Trends Cognit Sci 2 436-undefined

[5] Arnsten undefined(1993)undefined Neurobiol Aging 14 597-undefined

[6] Arnsten undefined(1992)undefined Psychopharmacology 108 159-undefined

[7] Arnsten undefined(1985)undefined Science 230 1273-undefined

[8] Arnsten undefined(1986)undefined Soc Neurosci Abstr 12 1464-undefined

[9] Arnsten undefined(1998)undefined Arch Gen Psychiatry 55 362-undefined

[10] Arnsten undefined(1988)undefined J Neurosci 8 4287-undefined